Search
for

    Glossary Angiotensin-Converting Enzyme

    regulates blood pressure by converting angiotensin I to angiotensin II

    Angiotensin-Converting Enzyme (ACE) is a protein that plays a crucial role in regulating blood pressure by converting angiotensin I, an inactive hormone, into angiotensin II, a potent vasoconstrictor that narrows blood vessels and increases blood pressure. ACE inhibitors are commonly used medications to treat high blood pressure and heart failure by blocking this enzyme's activity, thereby relaxing blood vessels and lowering blood pressure.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Association between angiotensin‐converting enzyme gene insertion deletion polymorphism and androgenetic alopecia susceptibility among Egyptian patients: A preliminary case‐controlled study Journal of Cosmetic Dermatology · 2021 · 1 citations
    2. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome European Journal of Endocrinology · 2012 · 16 citations
    3. The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review Microorganisms · 2021 · 52 citations
    4. Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs) Gynecological Endocrinology · 2013 · 12 citations
    5. Repurposing existing drugs for COVID-19: an endocrinology perspective BMC Endocrine Disorders · 2020 · 34 citations
    6. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    7. An Unusual Cause of Hair Loss Archives of dermatology · 2002 · 13 citations
    8. Lisinopril-Induced Alopecia: A Case Report Journal of Pharmacy Practice · 2016 · 8 citations
    9. [Drug induced alopecia]. PubMed · 1999 · 4 citations
    10. Sarcoidosis Presenting as Frontal Fibrosing Alopecia: A Master Mimicker or a Coincidental Finding? 2017 · 3 citations
    11. Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19 Ibn AL- Haitham Journal For Pure and Applied Science · 2024 · 2 citations
    12. ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion Journal of Cosmetic Dermatology · 2025 · 1 citations
    13. Culprits of Medication-Induced Telogen Effluvium, Part 2 Cutis · 2024
    14. Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach International Journal of Science and Research (IJSR) · 2022
    15. Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial European Urology Supplements · 2019
    16. Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses Journal of The American Academy of Dermatology · 2016
    17. QUINAPRIL 2004
    18. Bioactive peptides derived from food proteins preventing lifestyle‐related diseases BioFactors · 2000 · 223 citations
    19. Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride Journal of The American Academy of Dermatology · 2016
    20. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Reviews in endocrine and metabolic disorders · 2021 · 14 citations
    21. Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema Dermatology · 2015 · 11 citations
    22. Role of ACE2 polymorphism in COVID-19: impact of age Clinical Chemistry and Laboratory Medicine · 2021 · 6 citations
    23. Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care Journal of Human Hypertension · 2023 · 4 citations
    24. Nanocarriers for Improved Delivery of Angiotensin-(1-7) Elsevier eBooks · 2015
    25. Testosterone in COVID-19 – Foe, Friend or Fatal Victim? touchREVIEWS in Endocrinology · 2020 · 12 citations
    26. Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications Cureus · 2024 · 4 citations
    27. Congenital adrenal hyperplasia Dermatologic Therapy · 2008 · 16 citations
    28. Steroidogenesis in steroid related cancers University of Birmingham Institutional Research Archive (University of Birmingham) · 2016
    29. ENZYMES British journal of pharmacology · 2011 · 1 citations
    30. Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats Neuropharmacology · 2018 · 10 citations